Oct 2026· Alzheimer's Research & Therapy· Vol 18· 0 citations· 55 references
Medicine
TL;DR
Diabetes was associated with dementia throughout later life, with stronger associations at younger attained ages and among participants with a longer estimated interval since first ascertainment, and support considering the timing of diabetes ascertainment in cognitive risk assessment.
Abstract
Diabetes is associated with dementia, but how this association varies with attained age and cumulative exposure remains unclear. We integrated time-updated exposure histories with repeated age-specific landmark cohorts, enabling complementary evaluation of overall and age-conditional dementia risk. We analysed 18,028 dementia-free participants aged 50 years or older from the Health and Retirement Study. Incident dementia was classified using the Langa–Weir algorithm. Time-updated Cox models evaluated risk according to current diabetes status. Age-anchored landmark models used delayed entry at six prespecified ages from 50 to 75 years. Formal age interactions and competing mortality were also assessed. Diabetes was associated with higher dementia risk in the time-updated analysis (HR, 1.29; 95% CI, 1.19–1.41). The association attenuated with older attained age but remained evident across the landmark cohorts. An estimated interval exceeding 10 years since first diabetes ascertainment identified groups at higher risk. The findings remained consistent after accounting for competing death. Diabetes was associated with dementia throughout later life, with stronger associations at younger attained ages and among participants with a longer estimated interval since first ascertainment. These observational findings support considering the timing of diabetes ascertainment in cognitive risk assessment.
Background Type 2 diabetes mellitus (T2DM) is a well-established risk factor for dementia, and COVID-19 has been associated with persistent neurological and cognitive sequelae. However, whether this association extends beyond the early post-infection period among older adults with T2DM—a population with compounded vasc...
I.-W. Chen, Li-Chen Chang, C. Ho et al.· Frontiers in Aging Neuroscie...· 0 citations
Although many modifiable factors are linked to dementia risk, their association with dementia and Alzheimer disease (AD) mortality remains unclear. We aimed to identify late-life modifiable factors associated with these outcomes and assess sex differences. In the population-based Neurological Disorders in Central Spain...
J. Benito-León, J. I. Serrano, M. D. del Castillo et al.· Communications Health· 1 citation
This review synthesizes the evidence regarding Type 2 diabetes mellitus (T2DM) as a critical modifiable risk factor for dementia through a life-course lens. The primary purpose is to move beyond the general association and determine how the timing and severity of T2DM, specifically age at onset, duration of disease, an...
Mrityunjay Sivakumar, C. Sadacharan· Journal of Diabetes and Meta...· 0 citations
Marked BW change was associated with subsequent dementia risk in young and middle-aged adults with T2DM and depression, and BW trajectories may serve as clinically observable risk markers, although associations involving extreme BW change should be interpreted cautiously.
Hae Yeon Kang, Kyungdo Han, D. Yoon et al.· Diabetes, obesity and metabo...· 0 citations
OBJECTIVES
Exposure to modifiable dementia risk factors (MDRFs) contributes substantially to dementia risk across the life course. Less is known about persistence and changes in these factors during mid- and later life and how they relate to early neurophysiological changes associated with dementia. This study examined...
Joanne Allen, Michelle Kelly, G. Livingston et al.· International Psychogeriatri...· 0 citations
Background: Although the frailty index (FI) has been reported to associate with stroke risk in older adults, its relationship in those with gastrointestinal (GI) or liver diseases remains unclear. We examined this association in a Chinese cohort with these comorbidities. Methods: Using baseline data from the China Heal...
Xiao She, Hai-Yan Yang, Xiao Zhao et al.· Journal of Clinical Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.